Detalhe da pesquisa
1.
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2.
Diseases
; 12(1)2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38248380
2.
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.
Sci Rep
; 14(1): 7709, 2024 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565882
3.
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine.
NPJ Vaccines
; 9(1): 54, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459059
4.
Standardization, validation, and comparative evaluation of a faster and high-performance test for quantification of yellow fever neutralizing antibodies.
J Immunol Methods
; 522: 113568, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748728
5.
Case report: Regression of Glioblastoma after flavivirus infection.
Front Med (Lausanne)
; 10: 1192070, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37324152
6.
Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials.
Viruses
; 15(7)2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515173
7.
Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.
Viruses
; 14(9)2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146723
8.
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Vaccine
; 40(5): 798-810, 2022 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34969545
9.
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.
PLoS Negl Trop Dis
; 15(11): e0010002, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843469
10.
Antimicrobial activity and synergism of lactoferrin and lysozyme against cariogenic microorganisms.
Braz Dent J
; 25(2): 165-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25140723
11.
Antimicrobial Activity and Synergism of Lactoferrin and Lysozyme Against Cariogenic Microorganisms
Braz. dent. j
; 25(2): 165-169, Mar-Apr/2014. tab
Artigo
em Inglês
| LILACS | ID: lil-719216
12.
An evaluation of the expression profiles of salivary proteins lactoferrin and lysozyme and their association with caries experience and activity / Avaliação do padrão de expressão das proteínas salivares lactoferrina e lisozima e sua associação com experiência e atividade de cárie
Rev. odonto ciênc
; 25(4): 344-349, oct.-dec. 2010. tab
Artigo
em Inglês
| LILACS, BBO | ID: biblio-874244